The efficacy and safety of crizotinib in patients with ROS1 positiveadvanced stage NSCLC: The real-world experience from Turkey


KILIÇKAP S., ÖLMEZ Ö. F. , ÇİÇİN İ., DEMİRCİ U., ALAN Ö., ÇABUK D. , ...More

ESMO 2018, Munich, Germany, 19 - 23 October 2018, vol.29 identifier

  • Publication Type: Conference Paper / Full Text
  • Volume: 29
  • Doi Number: 10.1093/annonc/mdy292.023
  • City: Munich
  • Country: Germany